Spinal cord stimulation in Buerger's disease [4]

Annals of the Rheumatic Diseases

Volumn 61, Issue 12, 2002, Pages 1114-

  Pace, A V ^a   Saratzis, N ^b   Karokis, D ^a   Dalainas, D ^b   Kitas, G D ^a,c  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c The Guest Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTITHROMBOCYTIC AGENT; GUANETHIDINE; PROSTACYCLIN; VASODILATOR AGENT;

ANALGESIA; ANGIOGRAPHY; BUERGER DISEASE; CASE REPORT; CLINICAL FEATURE; HUMAN; LEG PAIN; LEG ULCER; LETTER; POSTOPERATIVE CARE; PRIORITY JOURNAL; SPINAL CORD STIMULATION; TREATMENT OUTCOME;

ELECTRIC STIMULATION THERAPY; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; PAIN, INTRACTABLE; SPINAL CORD; THROMBOANGIITIS OBLITERANS; WOUND HEALING;

EID: 0036892106     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.12.1114     Document Type: Letter

References (10)

1. Fiessinger JN, Scaler M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. Lancet 1990;335:555-7.
2. Stumpflen A, Ahmadi A, Attender A, Gschwandtner M, Hofmann S, Maca T, et al. Effects of transvenous regional guanethidine block in the treatment of critical finger ischaemia. Angiology 2000;51:115-22.
3. Sayin A, Bozhurt AK, Tuzun H, Vural FS, Erdog G, Ozer M. Surgical treatment of Buerger's disease. Experience with 216 patients. Cardiovasc Surg 1993;1:377-80.
4. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischaemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg 1999;29:928-35.
5. Talwar S, Jain S, Porwal R, Laddha BL, Prasad P. Pedicled omental transfer for limb salvage in Buerger's disease. Int J Cardiol 2000;72:127-32.
6. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results. J Vasc Surg 1998;38:964-73.
7. Croom JE, Foreman RD, Chandler MJ, Koss MC, Barron KW. Role of nitric oxide in cutaneous blood flow increase in the rat hindpaw during dorsal cord stimulation. Neurosurgery 1997;40:565-70.
8. Stanton-Hicks M, Salamon J. Stimulation of the central and peripheral nervous system for the control of pain. J Clin Neurophysiol 1997;14:46-62.
9. Ghajar AW, Miles JB. The differential effect of the level of spinal cord stimulation on patients with advanced peripheral vascular disease in the lower limbs. Br J Neurosurg 1998;12:402-8.
10. Claeys LG, Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 1996;15:344-9.